Verastem (VSTM) Treasury Shares (2011 - 2026)
Verastem (VSTM) recorded quarterly Treasury Shares of $2.2 million in Q1 2026, up 68.6% quarter-over-quarter from $1.3 million in Q4 2025, and up 20.95% on a YoY basis from $1.8 million in Q1 2025.
Verastem (VSTM) Treasury Shares (2011 - 2026) Analysis & Trends
Verastem's Treasury Shares history runs 14 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- In Q1 2026, Treasury Shares rose 20.95% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (up 20.95% YoY), while the FY2025 annual figure was $1.3 million, up 30.06% from the prior year.
- Treasury Shares was $2.2 million for Q1 2026 at Verastem, up from $1.3 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $2.6 million in Q2 2022 to a low of $142333.0 in Q2 2023.
- Historically, Treasury Shares has averaged $1.3 million across 5 years, with a median of $1.3 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Treasury Shares sank 94.53% in 2023, then surged 671.45% in 2024.
- A 5-year view of Treasury Shares shows it stood at $172909.0 in 2022, then gained by 21.04% to $209289.0 in 2023, then soared by 382.7% to $1.0 million in 2024, then jumped by 30.06% to $1.3 million in 2025, then soared by 68.6% to $2.2 million in 2026.
- The last three Treasury Shares figures came in at $2.2 million (Q1 2026), $1.3 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | 2.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.22 Mn |
| Mar 31, 2026 | 2.22 Mn |
| Dec 31, 2025 | 1.31 Mn |
| Dec 31, 2025 | 1.31 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.83 Mn |
| Mar 31, 2025 | 1.83 Mn |
| Dec 31, 2024 | 1.01 Mn |
| Dec 31, 2024 | 1.01 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 426,392.00 |
| Mar 31, 2024 | 426,392.00 |
| Dec 31, 2023 | 209,289.00 |
| Dec 31, 2023 | 209,289.00 |